A nanoparticulate dual scavenger for targeted therapy of inflammatory bowel disease
C Shi, J Dawulieti, F Shi, C Yang, Q Qin, T Shi… - Science …, 2022 - science.org
A therapeutic strategy that targets multiple proinflammatory factors in inflammatory bowel
disease (IBD) with minimal systemic side effects would be attractive. Here, we develop a …
disease (IBD) with minimal systemic side effects would be attractive. Here, we develop a …
[引用][C] A nanoparticulate dual scavenger for targeted therapy of inflammatory bowel disease
C Shi, J Dawulieti, F Shi, C Yang, Q Qin… - Science …, 2022 - ui.adsabs.harvard.edu
A nanoparticulate dual scavenger for targeted therapy of inflammatory bowel disease -
NASA/ADS Now on home page ads icon ads Enable full ADS view NASA/ADS A …
NASA/ADS Now on home page ads icon ads Enable full ADS view NASA/ADS A …
[HTML][HTML] A nanoparticulate dual scavenger for targeted therapy of inflammatory bowel disease
C Shi, J Dawulieti, F Shi, C Yang, Q Qin, T Shi… - Science …, 2022 - ncbi.nlm.nih.gov
A therapeutic strategy that targets multiple proinflammatory factors in inflammatory bowel
disease (IBD) with minimal systemic side effects would be attractive. Here, we develop a …
disease (IBD) with minimal systemic side effects would be attractive. Here, we develop a …
A nanoparticulate dual scavenger for targeted therapy of inflammatory bowel disease.
C Shi, J Dawulieti, F Shi, C Yang, Q Qin, T Shi… - Science …, 2022 - europepmc.org
A therapeutic strategy that targets multiple proinflammatory factors in inflammatory bowel
disease (IBD) with minimal systemic side effects would be attractive. Here, we develop a …
disease (IBD) with minimal systemic side effects would be attractive. Here, we develop a …
[PDF][PDF] A nanoparticulate dual scavenger for targeted therapy of inflammatory bowel disease
C Shi, J Dawulieti, F Shi, C Yang, Q Qin, T Shi, L Wang… - 2022 - researchgate.net
A therapeutic strategy that targets multiple proinflammatory factors in inflammatory bowel
disease (IBD) with minimal systemic side effects would be attractive. Here, we develop a …
disease (IBD) with minimal systemic side effects would be attractive. Here, we develop a …
A nanoparticulate dual scavenger for targeted therapy of inflammatory bowel disease
C Shi, J Dawulieti, F Shi, C Yang, Q Qin… - Science …, 2022 - pubmed.ncbi.nlm.nih.gov
A therapeutic strategy that targets multiple proinflammatory factors in inflammatory bowel
disease (IBD) with minimal systemic side effects would be attractive. Here, we develop a …
disease (IBD) with minimal systemic side effects would be attractive. Here, we develop a …